BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27992655)

  • 1. Use of 20% intravenous lipid emulsion for the treatment of loperamide toxicosis in a Collie homozygous for the ABCB1-1∆ mutation.
    Long WM; Sinnott VB; Bracker K; Thomas D
    J Vet Emerg Crit Care (San Antonio); 2017 May; 27(3):357-361. PubMed ID: 27992655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loperamide toxicity in a collie with the MDR1 mutation associated with ivermectin sensitivity.
    Sartor LL; Bentjen SA; Trepanier L; Mealey KL
    J Vet Intern Med; 2004; 18(1):117-8. PubMed ID: 14765742
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous fat emulsion as treatment for ivermectin toxicosis in three dogs homozygous for the ABCB1-1Δ gene mutation.
    Wright HM; Chen AV; Talcott PA; Poppenga RH; Mealey KL
    J Vet Emerg Crit Care (San Antonio); 2011 Dec; 21(6):666-72. PubMed ID: 22316260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of intravenous lipid emulsion to treat ivermectin toxicosis in a Border Collie.
    Clarke DL; Lee JA; Murphy LA; Reineke EL
    J Am Vet Med Assoc; 2011 Nov; 239(10):1328-33. PubMed ID: 22044330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe adverse effects of certain veterinary drugs in collies and collie-like dogs].
    van der Vlugt-Meijer RH
    Tijdschr Diergeneeskd; 2004 Sep; 129(17):556-7. PubMed ID: 15461375
    [No Abstract]   [Full Text] [Related]  

  • 6. Electroretinographic changes after intravenous lipid emulsion therapy in a dog and a foal with ivermectin toxicosis.
    Pollio D; Michau TM; Weaver E; Kuebelbeck KL
    Vet Ophthalmol; 2018 Jan; 21(1):82-87. PubMed ID: 27440451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ABCB1-1Delta mutation is not responsible for subchronic neurotoxicity seen in dogs of non-collie breeds following macrocyclic lactone treatment for generalized demodicosis.
    Bissonnette S; Paradis M; Daneau I; Silversides DW
    Vet Dermatol; 2009 Feb; 20(1):60-6. PubMed ID: 19152588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of high-dose insulin therapy and intravenous lipid emulsion to treat severe, refractory diltiazem toxicosis in a dog.
    Maton BL; Simmonds EE; Lee JA; Alwood AJ
    J Vet Emerg Crit Care (San Antonio); 2013; 23(3):321-7. PubMed ID: 23656275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loperamide-induced expression of immune and inflammatory genes in Collies associated with ivermectin sensitivity.
    Zhu M; Yancy HF; Deaver C; Jones YL; Myers MJ
    J Vet Pharmacol Ther; 2016 Apr; 39(2):131-7. PubMed ID: 26471945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine Toxicosis Treated with Intravenous Lipid Emulsion Therapy in a Dog.
    Hagley SP; Epstein SE; Stern JA; Poppenga R
    J Am Anim Hosp Assoc; 2020; 56(4):226-230. PubMed ID: 32412333
    [No Abstract]   [Full Text] [Related]  

  • 11. Clearance of plasma ivermectin with single pass lipid dialysis in 2 dogs.
    Londoño LA; Buckley GJ; Bolfer L; Bandt C
    J Vet Emerg Crit Care (San Antonio); 2017 Mar; 27(2):232-237. PubMed ID: 28117946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicology of Avermectins and Milbemycins (Macrocyclic Lactones) and the Role of P-Glycoprotein in Dogs and Cats.
    Merola VM; Eubig PA
    Vet Clin North Am Small Anim Pract; 2018 Nov; 48(6):991-1012. PubMed ID: 30139545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ibuprofen toxicosis in a dog with IV lipid emulsion.
    Bolfer L; McMichael M; Ngwenyama TR; O'Brien MA
    J Am Anim Hosp Assoc; 2014; 50(2):136-40. PubMed ID: 24446399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suspected synthetic cannabinoid toxicosis in a dog.
    Williams K; Wells RJ; McLean MK
    J Vet Emerg Crit Care (San Antonio); 2015; 25(6):739-44. PubMed ID: 26473510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breed is associated with the ABCB1-1Δ mutation in Australian dogs.
    Soussa RW; Woodward A; Marty M; Cannon CM
    Aust Vet J; 2020 Mar; 98(3):79-83. PubMed ID: 31743433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of ABCB1:c.227_230delATAG mutation in affected dog breeds from European countries.
    Firdova Z; Turnova E; Bielikova M; Turna J; Dudas A
    Res Vet Sci; 2016 Jun; 106():89-92. PubMed ID: 27234542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of IV lipid emulsion for lipophilic drug toxicities.
    Kaplan A; Whelan M
    J Am Anim Hosp Assoc; 2012; 48(4):221-7. PubMed ID: 22611209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of gas chromatography-mass spectrometry for definitive diagnosis of synthetic cannabinoid toxicity in a dog.
    Kelmer E; Shimshoni JA; Merbl Y; Kolski O; Klainbart S
    J Vet Emerg Crit Care (San Antonio); 2019 Sep; 29(5):573-577. PubMed ID: 31342645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of the Canine ABCB1-1Δ Mutation on Sedation after Intravenous Administration of Acepromazine.
    Deshpande D; Hill KE; Mealey KL; Chambers JP; Gieseg MA
    J Vet Intern Med; 2016; 30(2):636-41. PubMed ID: 26822006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breed distribution of the ABCB1-1Delta (multidrug sensitivity) polymorphism among dogs undergoing ABCB1 genotyping.
    Mealey KL; Meurs KM
    J Am Vet Med Assoc; 2008 Sep; 233(6):921-4. PubMed ID: 18795852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.